IP Library Granted Patent US 9,587,212
Granted Patent B2
US 9,587,212 · App. 15/232,405 · Granted Mar 7, 2017

Apparatus and methods for biosynthetic production of cannabinoids

Inventors: Robert Winnicki (Cambridge, MA); Marc Donsky (Denver, CO); Mingyang Sun (Dublin, IE); Richard Peet (Washington, DC)
Assignee: Full Spectrum Laboratories Limited
C12M21/18C12M29/00C12M41/12C12M41/26C12M41/30C12M41/32C12M41/40C12M41/48C12N9/0004C12P7/22C12P7/42C12P17/06C12Y121/03C12Y121/03007C12Y121/03008
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,587,212
App. No.
15/232,405
Granted
Mar 7, 2017
Kind
B2
Abstract

The present invention provides an apparatus and methods for producing tetrahydrocannabinolic acid (THCA), cannabichromenic acid (CBCA) and cannabichromenic acid (CBCA) in different ratios. The apparatus comprises: (i) a bioreactor comprising (a) an automated supply system configured to deliver a first automated supply of cannabigerolic acid (CBGA), a cannabinoid acid synthase, and a reaction mixture; and (b) a second automated system to cease the reaction; (ii) a controller configured to modify a property of the reaction mixture to produce the desired products; and (iii) an extractor configured to recover the tetrahydrocannabinolic acid (THCA), cannabichromenic acid (CBCA) or cannabidiolic acid (CBDA) and cannabichromenic acid.

Claims (8)

1. A system for producing cannabinoids wherein the system comprises:

a bioreactor comprising cells stably transformed with one or more cannabinoid biosynthetic genes;

(ii) a reaction mixture comprising cannabigerolic acid (CBGA) as a reagent; and

(iii) a controller configured to modify the pH of the reaction mixture to modify the ratio of the cannabinoid products.

2. The system of claim 1 , wherein the cells are selected from the group consisting of fungal, animal, algal, and bacterial.

3. The system of claim 2 , wherein the fungal cells are yeast cells.

4. The system of claim 1 , wherein the cannabinoid biosynthetic gene is the tetrahydrocannabinolic acid (THCA) synthase gene.

5. The system of claim 1 , wherein the cannabinoid biosynthetic gene is the cannabidiolic acid (CBDA) synthase gene.

Assignments (6)
SECURITY INTEREST Recorded Nov 23, 2021
From: TEEWINOT TECHNOLOGIES LIMITED
To: TUATARA CAPITAL FUND I, L.P.; TUATARA CAPITAL PARALLEL FUND I, L.P.
Reel/Frame 058194/0448 →
SECURITY INTEREST Recorded Nov 23, 2021
From: TEEWINOT LIFE SCIENCES CORPORATION; TEEWINOT TECHNOLOGIES LIMITED
To: TUATARA CAPITAL FUND I, L.P.; TUATARA CAPITAL PARALLEL FUND I, L.P.
Reel/Frame 058194/0474 →
SECURITY INTEREST Recorded Nov 22, 2021
From: TEEWINOT TECHNOLOGIES LIMITED
To: TUATARA CAPITAL FUND I, L.P.; TUATARA CAPITAL PARALLEL FUND I, L.P.
Reel/Frame 058180/0377 →
SECURITY INTEREST Recorded Nov 22, 2021
From: TEEWINOT LIFE SCIENCES CORPORATION; TEEWINOT TECHNOLOGIES LIMITED
To: TUATARA CAPITAL FUND I, L.P.; TUATARA CAPITAL PARALLEL FUND I, L.P.
Reel/Frame 058182/0033 →
SECURITY INTEREST Recorded Aug 24, 2020
From: TEEWINOT TECHNOLOGIES, LTD.
To: TUATARA CAPITAL FUND I, L.P.
Reel/Frame 053582/0897 →
CHANGE OF NAME Recorded Dec 8, 2017
From: FULL SPECTRUM LABORATORIES LIMITED
To: TEEWINOT TECHNOLOGIES LIMITED
Reel/Frame 044804/0125 →
Continuity (4)
Continuation 15158565 · May 18, 2016
Continuation 14835444 · Aug 25, 2015
Provisional Application 62041521 · Aug 25, 2014
Related Publication 20160340629A1 · Nov 24, 2016